ad image

Eczema

1 / 1
Pfizer

Pfizer Announces Positive Top-Line Results from Phase 3 Study in Patients with Moderate to Severe Atopic Dermatitis

Pfizer

PR-M05-19-NI-055May 20, 2019
Novartis Will Spend Up to More Than $1 Billion on an Eczema Candidate
Drug Development

Novartis Will Spend Up to More Than $1 Billion on an Eczema Candidate

Emilie Branch

Pharma's Almanac

PAO-M07-18-NI-017Jul 24, 2018
1 / 1